{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:32:13Z","timestamp":1784302333314,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejogrb.2025.114111","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:11:27Z","timestamp":1749208287000},"page":"114111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Fertility-sparing strategies in borderline and malignant ovarian tumors: a comparative analysis of international guideline recommendations"],"prefix":"10.1016","volume":"312","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5408-6055","authenticated-orcid":false,"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114111_b0005","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2025.114111_b0010","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.18.02419","article-title":"Management of rare ovarian cancer histologies","volume":"37","author":"Gershenson","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0015","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S1470-2045(20)30091-7","article-title":"ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers","volume":"21","author":"Sessa","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0020","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0025","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/annonc\/mdw311","article-title":"Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues","volume":"27","author":"Bentivegna","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.6004\/jnccn.2024.0052","article-title":"NCCN guidelines(R) insights: ovarian cancer\/fallopian tube cancer\/primary peritoneal cancer, Version 3.2024","volume":"22","author":"Liu","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejogrb.2025.114111_b0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonzalez-Martin","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0040","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/S1470-2045(24)00262-6","article-title":"Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE","volume":"25","author":"Morice","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejogrb.2024.06.025","article-title":"British gynaecological cancer society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: recommendations for practice update 2024","volume":"300","author":"Moss","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0050","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1007\/s12094-024-03531-3","article-title":"SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)","volume":"26","author":"Perez-Fidalgo","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0060","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/ijgc-2023-004610","article-title":"Low-grade serous ovarian cancer: expert consensus report on the state of the science","volume":"33","author":"Grisham","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ygyno.2021.05.033","article-title":"Influence of lymph node involvement or lymphadenectomy on prognosis of patients with borderline ovarian tumors: a systematic review and meta-analysis","volume":"162","author":"Fan","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/ijgc-2023-004327","article-title":"Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers","volume":"33","author":"Kim","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0075","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1245\/s10434-018-6412-y","article-title":"Stage- and histologic subtype-dependent frequency of lymph node metastases in patients with epithelial ovarian cancer undergoing systematic pelvic and paraaortic lymphadenectomy","volume":"25","author":"Heitz","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ijgc-2023-004955","article-title":"Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes","volume":"34","author":"Algera","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0085","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1813254","article-title":"Mucinous ovarian carcinoma","volume":"380","author":"Morice","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2025.114111_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113398","article-title":"Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?","volume":"195","author":"Bizzarri","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0095","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/CCO.0000000000000860","article-title":"Use of staging for sex cord stromal tumours","volume":"34","author":"Negri","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2020.04.047","article-title":"Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy","volume":"157","author":"Nasioudis","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2017.10.010","article-title":"Fertility-preserving surgery for advanced stage ovarian germ cell tumors","volume":"147","author":"Nasioudis","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0110","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/ijgc-2022-003806","article-title":"Primary mucinous ovarian cancer: options for surgery and chemotherapy","volume":"32","author":"Kurnit","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"46","key":"10.1016\/j.ejogrb.2025.114111_b0115","first-page":"e1","article-title":"The role of appendectomy for mucinous ovarian neoplasms","volume":"208","author":"Lin","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2013.12.011","article-title":"Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms","volume":"132","author":"Elias","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2016.10.041","article-title":"Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? a retrospective study and meta-analysis","volume":"144","author":"Cheng","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.23736\/S2724-606X.22.05115-6","article-title":"Fertility sparing treatment for bilateral borderline ovarian tumor: a case report and management strategy explication","volume":"75","author":"Ronsini","year":"2023","journal-title":"Minerva Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0135","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ygyno.2021.03.023","article-title":"Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. an analysis from the MITO14 study database","volume":"161","author":"Falcone","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ygyno.2022.02.018","article-title":"Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: analysis from the MITO14 study database","volume":"165","author":"Falcone","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0145","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1245\/s10434-020-09250-7","article-title":"Results after conservative surgery of stage II\/III serous borderline ovarian tumors","volume":"28","author":"Gouy","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.fertnstert.2015.03.038","article-title":"Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors","volume":"104","author":"Helpman","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114111_b0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ygyno.2023.09.015","article-title":"All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer","volume":"178","author":"Jorgensen","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2023.08.013","article-title":"Clinical implications of histologic subtypes on survival outcomes in primary mucinous ovarian carcinoma","volume":"177","author":"Lim","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1634\/theoncologist.2017-0310","article-title":"Results of fertility-sparing surgery for expansile and infiltrative mucinous ovarian cancers","volume":"23","author":"Gouy","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.ejogrb.2025.114111_b0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2020.01.039","article-title":"Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary","volume":"248","author":"Nasioudis","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0175","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ejso.2021.01.016","article-title":"Fertility sparing surgery for early-stage clear cell carcinoma of the ovary; a systematic review and analysis of obstetric outcomes","volume":"47","author":"Prodromidou","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0180","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/ijgc-2020-001716","article-title":"Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature","volume":"30","author":"Nasioudis","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0185","doi-asserted-by":"crossref","first-page":"e7132","DOI":"10.1002\/cam4.7132","article-title":"Outcomes after fertility-sparing surgery of early-stage ovarian cancer: a nationwide population-based study","volume":"13","author":"Lee","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejogrb.2025.114111_b0190","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/ijgc-2021-003241","article-title":"Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes","volume":"32","author":"Bergamini","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2023.07.007","article-title":"Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence","volume":"176","author":"Liu","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2018.09.004","article-title":"Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in apparent stage I adult ovarian granulosa cell tumors","volume":"151","author":"Wang","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0205","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/IGC.0b013e3182236582","article-title":"Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study","volume":"21","author":"Mangili","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0210","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/ijgc-2024-005534","article-title":"Fertility outcomes in stage I ovarian immature teratomas","volume":"34","author":"Marino","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2025.114111_b0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/AOG.0000000000005530","article-title":"Fertility-sparing surgery for stage I epithelial ovarian cancer","volume":"144","author":"Song","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114111_b0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2022.01.019","article-title":"The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: a systematic review and meta-analysis","volume":"165","author":"Raimondo","year":"2022","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:26:38Z","timestamp":1753453598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525003872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S0301211525003872"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114111","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility-sparing strategies in borderline and malignant ovarian tumors: a comparative analysis of international guideline recommendations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114111"}}